Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell entities : Tscan therapeutics inc save search
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies- Completion of facility supports upcoming clinical milestones including expected multiple fourth quarter IND filings -
Published: 2021-12-02 (Crawled : 13:30) - biospace.com/
TCRX | News 3 d | $7.235 -0.34% 6.3K
|
Professional, Scientific, and T...
|
| O: -10.66%
H: 0.0%
C: 0.0%
BXP 4 | $62.56 -0.59% 110K
|
Finance
|
| O: -2.97%
H: 5.04%
C: 4.17%
therapeutics scan milestone t-cell
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies
Published: 2021-12-02 (Crawled : 12:30) - globenewswire.com
TCRX | News 3 d | $7.235 -0.34% 6.3K
|
Professional, Scientific, and T...
|
| O: -10.66%
H: 0.0%
C: 0.0%
BXP 4 | $62.56 -0.59% 110K
|
Finance
|
| O: -2.97%
H: 5.04%
C: 4.17%
therapeutics scan therapy t-cell
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit
Published: 2021-07-21 (Crawled : 12:00) - globenewswire.com
TCRX | News 3 d | $7.235 -0.34% 6.3K
|
Professional, Scientific, and T...
|
| O: 2.73%
H: 0.0%
C: -9.54%
PSTX | $2.12 -1.85% 33K
|
Health Technology
|
| O: 0.55%
H: 1.65%
C: 1.1%
covid disease media infectious disease therapy t-cell
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $1.93 64.96% 55M
|
AMST | $3.14 57.0% 59M
|
Technology Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
WHLM | $6.61 30.12% 400K
|
Commercial Services
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.